Enhancement of bone regeneration by dual release of a macrophage recruitment agent and platelet-rich plasma from gelatin hydrogels

Biomaterials

Volumn 35, Issue 1, 2014, Pages 214-224

  Kim, Yang Hee ^a   Furuya, Hiroyuki ^a   Tabata, Yasuhiko ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Bone regeneration; Controlled release; Gelatin hydrogel; Macrophages; Platelet rich plasma (PRP); S1P1 agonist (SEW2871)

Indexed keywords

BONE REGENERATION; CONTROLLED RELEASE; GELATIN HYDROGELS; PLATELET-RICH PLASMA; S1P1 AGONIST (SEW2871);

BONE; MACROPHAGES; MICELLES; PLASMA (HUMAN);

HYDROGELS;

5 (4 PHENYL 5 TRIFLUOROMETHYL 2 THIENYL) 3 (3 TRIFLUOROMETHYLPHENYL) 1,2,4 OXADIAZOLE; GELATIN; INTERLEUKIN 10; OSTEOPROTEGERIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEFECT; BONE REGENERATION; BONE REMODELING; CONTROLLED STUDY; GENE EXPRESSION; HYDROGEL; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MACROPHAGE MIGRATION; MICELLE; NONHUMAN; PRIORITY JOURNAL; RAT; THROMBOCYTE RICH PLASMA;

RATTUS;

BONE REGENERATION; CONTROLLED RELEASE; GELATIN HYDROGEL; MACROPHAGES; PLATELET RICH PLASMA (PRP); S1P(1) AGONIST (SEW2871);

ANIMALS; BONE AND BONES; BONE REGENERATION; CELL MOVEMENT; CYTOKINES; GELATIN; HYDROGELS; INFLAMMATION MEDIATORS; MACROPHAGES; OSTEOPROTEGERIN; PLATELET-RICH PLASMA; RATS; RATS, INBRED F344;

EID: 84887016664     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.09.103     Document Type: Article

References (65)

1. Mehta M., Schmidt-Bleek K., Duda G.N., Mooney D.J. Biomaterial delivery of morphogens to mimic the natural healing cascade in bone. Adv Drug Deliv Rev 2012, 64:1257-1276.
2. Ingber D.E., Mow V.C., Butler D., Niklason L., Huard J., Mao J., et al. Tissue engineering and developmental biology: going biomimetic. Tissue Eng 2006, 12:3265-3283.
3. Kolar P., Schmidt-Bleek K., Schell H., Gaber T., Toben D., Schmidmaier G., et al. The early fracture hematoma and its potential role in fracture healing. Tissue Eng Part B Rev 2010, 16:427-434.
4. Mountziaris P.M., Mikos A.G. Modulation of the inflammatory response for enhanced bone tissue regeneration. Tissue Eng Part B Rev 2008, 14:179-186.
5. Allison A.C., Ferluga J., Prydz H., Schorlemmer H.U. The role of macrophage activation in chronic inflammation. Agents and Actions 1978, 8:27-35.
6. Soehnlein O., Lindbom L. Phagocyte partnership during the onset and resolution of inflammation. Nat Rev Immunol 2010, 10:427-439.
7. Mountziaris P.M., Spicer P.P., Kasper F.K., Mikos A.G. Harnessing and modulating inflammation in strategies for bone regeneration. Tissue Eng Part B Rev 2011, 17:393-402.
8. Kharraz Y., Guerra J., Mann C.J., Serrano A.L., Munoz-Canoves P. Macrophage plasticity and the role of inflammation in skeletal muscle repair. Mediators Inflamm 2013, 2013:491497.
9. Herold S., Mayer K., Lohmeyer J. Acute lung injury: how macrophages orchestrate resolution of inflammation and tissue repair. Front Immunol 2011, 2:65.
10. Eming S.A., Krieg T., Davidson J.M. Inflammation in wound repair: molecular and cellular mechanisms. JInvest Dermatol 2007, 127:514-525.
11. Khanna S., Biswas S., Shang Y., Collard E., Azad A., Kauh C., et al. Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice. PLoS One 2010, 5:e9539.
12. Maruyama K., Asai J., Ii M., Thorne T., Losordo D.W., D'Amore P.A. Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. Am J Pathol 2007, 170:1178-1191.
13. Mokarram N., Merchant A., Mukhatyar V., Patel G., Bellamkonda R.V. Effect of modulating macrophage phenotype on peripheral nerve repair. Biomaterials 2012, 33:8793-8801.
14. Takabe K., Paugh S.W., Milstien S., Spiegel S. "Inside-out" signaling of sphingosine-1-phosphate: therapeutic targets. Pharmacol Rev 2008, 60:181-195.
15. Lien Y.H., Yong K.C., Cho C., Igarashi S., Lai L.W. S1P(1)-selective agonist, SEW2871, ameliorates ischemic acute renal failure. Kidney Int 2006, 69:1601-1608.
16. Spiegel S., Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 2003, 4:397-407.
17. Jo E., Sanna M.G., Gonzalez-Cabrera P.J., Thangada S., Tigyi G., Osborne D.A., et al. S1P1-selective invivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate. Chem Biol 2005, 12:703-715.
18. Marx R.E., Carlson E.R., Eichstaedt R.M., Schimmele S.R., Strauss J.E., Georgeff K.R. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998, 85:638-646.
19. Tischler M. Platelet rich plasma. The use of autologous growth factors to enhance bone and soft tissue grafts. NY State Dent J 2002, 68:22-24.
20. Matsui M., Tabata Y. Enhanced angiogenesis by multiple release of platelet-rich plasma contents and basic fibroblast growth factor from gelatin hydrogels. Acta Biomater 2012, 8:1792-1801.
21. Kurita J., Miyamoto M., Ishii Y., Aoyama J., Takagi G., Naito Z., et al. Enhanced vascularization by controlled release of platelet-rich plasma impregnated in biodegradable gelatin hydrogel. Ann Thorac Surg 2011, 92:837-844.
22. Hokugo A., Ozeki M., Kawakami O., Sugimoto K., Mushimoto K., Morita S., et al. Augmented bone regeneration activity of platelet-rich plasma by biodegradable gelatin hydrogel. Tissue Eng 2005, 11:1224-1233.
23. Nagae M., Ikeda T., Mikami Y., Hase H., Ozawa H., Matsuda K., et al. Intervertebral disc regeneration using platelet-rich plasma and biodegradable gelatin hydrogel microspheres. Tissue Eng 2007, 13:147-158.
24. Kimura Y., Tabata Y. Controlled release of stromal-cell-derived factor-1 from gelatin hydrogels enhances angiogenesis. JBiomater Sci Polym Ed 2010, 21:37-51.
25. Tanigo T., Takaoka R., Tabata Y. Sustained release of water-insoluble simvastatin from biodegradable hydrogel augments bone regeneration. JControl Release 2010, 143:201-206.
26. Giuseppe I., Sebastiano A., Francesco E.I., Robert J.B., Libuse A.B. Calcium sulfate and platelet-rich plasma make a novel osteoinductive biomaterial for bone regeneration. JTransl Med 2007, 5:13.
27. Ozeki M., Tabata Y. Invivo degradability of hydrogels prepared from different gelatins by various cross-linking methods. JBiomater Sci Polym Ed 2005, 16:549-561.
28. Virk M.S., Conduah A., Park S.H., Liu N., Sugiyama O., Cuomo A., et al. Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2 expression on the quality of bone repair in a rat femoral defect model. Bone 2008, 42:921-931.
29. Schmitz J.P., Hollinger J.O. The critical size defect as an experimental model forcraniomandibulofacial nonunions. Clin Orthopaedics Relat Res 1986, 299-308.
30. Loell I., Lundberg I.E. Can muscle regeneration fail in chronic inflammation: a weakness in inflammatory myopathies?. JIntern Med 2011, 269:243-257.
31. Schindeler A., McDonald M.M., Bokko P., Little D.G. Bone remodeling during fracture repair: the cellular picture. Semin Cell Dev Biol 2008, 19:459-466.
32. Gerstenfeld L.C., Cullinane D.M., Barnes G.L., Graves D.T., Einhorn T.A. Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. JCell Biochem 2003, 88:873-884.
33. Koh T.J., DiPietro L.A. Inflammation and wound healing: the role of the macrophage. Expert Rev Mol Med 2011, 13:e23.
34. Mahdavian Delavary B., van der Veer W.M., van Egmond M., Niessen F.B., Beelen R.H. Macrophages in skin injury and repair. Immunobiology 2011, 216:753-762.
35. Takahashi Y., Yamamoto M., Tabata Y. Enhanced osteoinduction by controlled release of bone morphogenetic protein-2 from biodegradable sponge composed of gelatin and β-tricalcium phosphate. Biomaterials 2005, 26:4856-4865.
36. Yamamoto T., Tabata Y., Hong L., Miyamoto S., Hashimoto N., Ikada Y. Bone regeneration by transforming growth factor β1 released from a biodegradable hydrogel. JControl Release 2000, 64:133-142.
37. Kimura Y., Ozeki M., Inamoto T., Tabata Y. Adipose tissue engineering based on human preadipocytes combined with gelatin microspheres containing basic fibroblast growth factor. Biomaterials 2003, 24:2513-2521.
38. Kohara H., Tajima S., Yamamoto M., Tabata Y. Angiogenesis induced by controlled release of neuropeptide substance P. Biomaterials 2010, 31:8617-8625.
39. Hosseinkhani H., Hosseinkhani M., Tian F., Kobayashi H., Tabata Y. Ectopic bone formation in collagen sponge self-assembled peptide-amphiphile nanofibers hybrid scaffold in a perfusion culture bioreactor. Biomaterials 2006, 27:5089-5098.
40. Saito T., Tabata Y. Preparation of gelatin hydrogels incorporating low-molecular-weight heparin for anti-fibrotic therapy. Acta Biomater 2012, 8:646-652.
41. Gratchev A., Kzhyshkowska J., Kannookadan S., Ochsenreiter M., Popova A., Yu X., et al. Activation of a TGF-beta-specific multistep gene expression program in mature macrophages requires glucocorticoid-mediated surface expression of TGF-beta receptor II. JImmunol 2008, 180:6553-6565.
42. Ratanavaraporn J., Furuya H., Tabata Y. Local suppression of pro-inflammatory cytokines and the effects in BMP-2-induced bone regeneration. Biomaterials 2012, 33:304-316.
43. Xia Z., Triffitt J.T. Areview on macrophage responses to biomaterials. Biomed Mater 2006, 1:R1-R9.
44. Anderson J.M., Rodriguez A., Chang D.T. Foreign body reaction to biomaterials. Semin Immunol 2008, 20:86-100.
45. Chen L., Tredget E.E., Wu P.Y.G., Wu Y. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One 2008, 3:e1886.
46. Maggini J., Mirkin G., Bognanni I., Holmberg J., Piazzon I.M., Nepomnaschy I., et al. Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PloS One 2010, 5:e9252.
47. Kitaori T., Ito H., Schwarz E.M., Tsutsumi R., Yoshitomi H., Oishi S.N., et al. Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. Arthritis Rheum 2009, 60:813-823.
48. Zhou B., Han Z.C., Poon M.C., Pu W. Mesenchymal stem/stromal cells (MSC) transfected with stromal derived factor 1 (SDF-1) for therapeutic neovascularization: enhancement of cell recruitment and entrapment. Med Hypotheses 2007, 68:1268-1271.
49. Willenborg S., Lucas T., van Loo G., Knipper J.A., Krieg T., Haase I.B., et al. CCR2 recruits an inflammatory macrophage subpopulation critical for angiogenesis in tissue repair. Blood 2012, 120:613-625.
50. Xing Z., Lu C., Hu D., Yu Y.Y., Wang X., Colnot C., et al. Multiple roles for CCR2 during fracture healing. Dis Model Mech 2010, 3:451-458.
51. Lee H.N., Surh Y.J. Therapeutic potential of resolvins in the prevention and treatment of inflammatory disorders. Biochem Pharmacol 2012, 84:1340-1350.
52. Brown B.N., Ratner B.D., Goodman S.B., Amar S., Badylak S.F. Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine. Biomaterials 2012, 33:3792-3802.
53. Thomas M.V., Puleo D.A. Infection, inflammation, and bone regeneration: a paradoxical relationship. JDent Res 2011, 90:1052-1061.
54. Bhardwaj U., Sura R., Papadimitrakopoulos F., Burgess D.J. Controlling acute inflammation with fast releasing dexamethasone-PLGA microsphere/pva hydrogel composites for implantable devices. JDiabetes Sci Technol 2007, 1:8-17.
55. Glant T., Jacobs J. Response of three murine macrophage populations to particulate debris: bone resorption in organ cultures. JOrthop Res 1994, 12:720-731.
56. Lassus J., Salo J., Jiranek W.A., Santavirta S., Nevalainen J., Matucci-Cerinic M., et al. Macrophage activation results in bone resorption. Clin Orthop Relat Res 1998, 352:7-15.
57. Hamilton J.A., Tak P.P. The dynamics of macrophage lineage populations in inflammatory and autoimmune diseases. Arthritis Rheum 2009, 60:1210-1221.
58. Blom A.B., Van Lent P.L., Holthuysen A.E., Van der Kraan P.M., Roth J., Van Rooijen N., et al. Synovial lining macrophages mediate osteophyte formation during experimental osteoarthritis. Osteoarthritis Cartilage 2004, 12:627-635.
59. Van Lent P.L., Blom A.B., van der Kraan P., Holthuysen A.E., Vitters E., van Rooijen N., et al. Crucial role of synovial lining macrophages in the promotion of transforming growth factor β-mediated osteophyte formation. Arthritis Rheum 2004, 50:103-111.
60. Cenci S., Weitzmann M.N., Gentile M.A., Aisa M.C., Pacifici R. M-CSF neutralization and egr-1 deficiency prevent ovariectomy-induced bone loss. JClin Invest 2000, 105:1279-1287.
61. Kaneko M., Tomita T., Nakase T., Ohsawa Y., Seki H., Takeuchi E., et al. Expression of proteinases and inflammatory cytokines in subchondral bone regions in the destructive joint of rheumatoid arthritis. Rheumatology (Oxford) 2001, 40:247-255.
62. Gong D., Shi W., Yi S.J., Chen H., Groffen J., Heisterkamp N. TGFβ signaling plays a critical role in promoting alternative macrophage activation. BMC Immunol 2012, 13:31.
63. Galliera E., Corsi M.M., Banfi G. Platelet rich plasma therapy: inflammatory molecules involved in tissue healing. JBiol Regul Homeost Agents 2012, 26:35S-42S.
64. Kim J., Hematti P. Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. Exp Hematol 2009, 37:1445-1453.
65. Shi Y., Hu G., Su J., Li W., Chen Q., Shou P., et al. Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair. Cell Res 2010, 20:510-518.